Literature DB >> 20886281

RANTES deficiency attenuates autoantibody-induced glomerulonephritis.

Chun Xie1, Kui Liu, Yuyang Fu, Xiangmei Qin, Geetha Jonnala, Tao Wang, Hong W Wang, Michael Maldonado, Xin J Zhou, Chandra Mohan.   

Abstract

Experimental autoimmune nephritis in mice and spontaneous lupus nephritis are both associated with elevated expression of several chemokines in the kidneys. Nevertheless, the role that different chemokines play in mediating renal inflammation is far from complete. This study focuses on elucidating the functional role of RANTES, a chemokine that has been noted to be hyper-expressed within the kidneys, both in experimental renal disease as well as in spontaneous lupus nephritis. To elucidate if RANTES was essential for immune-mediated glomerulonephritis, DBA/1 mice that are highly sensitive to nephrotoxic serum nephritis were rendered RANTES-deficient and then tested for disease susceptibility. Nephritis-sensitive DBA/1 mice expressed more RANTES within the diseased kidneys. Compared to wild-type DBA/1 mice, RANTES-deficient DBA/1 mice developed significantly less proteinuria, azotemia, and renal inflammation, with reduced crescent formation and tubulo-interstitial nephritis. These findings indicate that RANTES ablation attenuates immune-mediated nephritis and suggest that this chemokine could be a potential therapeutic target in these diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20886281     DOI: 10.1007/s10875-010-9470-x

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  39 in total

1.  The chemokine receptor antagonist AOP-RANTES reduces monocyte infiltration in experimental glomerulonephritis.

Authors:  U Panzer; A Schneider; J Wilken; D A Thompson; S B Kent; R A Stahl
Journal:  Kidney Int       Date:  1999-12       Impact factor: 10.612

2.  A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation.

Authors:  Hans-Joachim Anders; Volker Vielhauer; Michael Frink; Yvonne Linde; Clemens D Cohen; Simone M Blattner; Matthias Kretzler; Frank Strutz; Matthias Mack; Hermann-Josef Gröne; James Onuffer; Richard Horuk; Peter J Nelson; Detlef Schlöndorff
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

3.  Gene transfer of RANTES elicits autoimmune renal injury in MRL-Fas(1pr) mice.

Authors:  K J Moore; T Wada; S D Barbee; V R Kelley
Journal:  Kidney Int       Date:  1998-06       Impact factor: 10.612

4.  Circulating levels of beta-chemokines in systemic lupus erythematosus.

Authors:  H Kaneko; H Ogasawara; T Naito; H Akimoto; S Lee; T Hishikawa; I Sekigawa; Y Tokano; Y Takasaki; S I Hirose; H Hashimoto
Journal:  J Rheumatol       Date:  1999-03       Impact factor: 4.666

5.  Relationship between serum RANTES levels and radiological progression in rheumatoid arthritis patients treated with methotrexate.

Authors:  L Boiardi; P Macchioni; R Meliconi; L Pulsatelli; A Facchini; C Salvarani
Journal:  Clin Exp Rheumatol       Date:  1999 Jul-Aug       Impact factor: 4.473

6.  Expression of chemokines and their receptors in nephrotoxic serum nephritis.

Authors:  E Schadde; M Kretzler; B Banas; B Luckow; K Assmann; D Schlöndorff
Journal:  Nephrol Dial Transplant       Date:  2000-07       Impact factor: 5.992

Review 7.  Glomerulonephritis, Th1 and Th2: what's new?

Authors:  P G Tipping; A R Kitching
Journal:  Clin Exp Immunol       Date:  2005-11       Impact factor: 4.330

8.  Abnormal expression of chemokine receptors on T-cells from patients with systemic lupus erythematosus.

Authors:  C Eriksson; K Eneslätt; J Ivanoff; S Rantapää-Dahlqvist; K G Sundqvist
Journal:  Lupus       Date:  2003       Impact factor: 2.911

9.  Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1 beta production by synovial T cells.

Authors:  E Robinson; E C Keystone; T J Schall; N Gillett; E N Fish
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

10.  CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration.

Authors:  Hans-Joachim Anders; Michael Frink; Yvonne Linde; Bernard Banas; Markus Wörnle; Clemens D Cohen; Volker Vielhauer; Peter J Nelson; Hermann-Josef Gröne; Detlef Schlöndorff
Journal:  J Immunol       Date:  2003-06-01       Impact factor: 5.422

View more
  8 in total

Review 1.  Biomarkers for kidney involvement in pediatric lupus.

Authors:  Beatrice Goilav; Chaim Putterman; Tamar B Rubinstein
Journal:  Biomark Med       Date:  2015       Impact factor: 2.851

2.  Deficiency in IRAK4 activity attenuates manifestations of murine Lupus.

Authors:  Michael Murphy; Goutham Pattabiraman; Tissa T Manavalan; Andrei E Medvedev
Journal:  Eur J Immunol       Date:  2017-03-31       Impact factor: 5.532

Review 3.  Investigating mechanisms of chronic kidney disease in mouse models.

Authors:  Allison A Eddy; Jesús M López-Guisa; Daryl M Okamura; Ikuyo Yamaguchi
Journal:  Pediatr Nephrol       Date:  2011-06-22       Impact factor: 3.714

4.  Clinical value of urinary cytokines/chemokines as prognostic markers in patients with crescentic glomerulonephritis.

Authors:  Junseok Jeon; Jeeeun Park; Hyo Jin Boo; Kyeong Eun Yang; Cheol-Jung Lee; Jung Eun Lee; Kyunga Kim; Ghee Young Kwon; Wooseong Huh; Dae Joong Kim; Yoon-Goo Kim; Hye Ryoun Jang
Journal:  Sci Rep       Date:  2022-06-17       Impact factor: 4.996

5.  The Fli-1 transcription factor regulates the expression of CCL5/RANTES.

Authors:  Mara L Lennard Richard; Shuzo Sato; Eiji Suzuki; Sarah Williams; Tamara K Nowling; Xian K Zhang
Journal:  J Immunol       Date:  2014-08-06       Impact factor: 5.422

6.  Glutathione S-transferase Mu 2-transduced mesenchymal stem cells ameliorated anti-glomerular basement membrane antibody-induced glomerulonephritis by inhibiting oxidation and inflammation.

Authors:  Yajuan Li; Mei Yan; Jichen Yang; Indu Raman; Yong Du; Soyoun Min; Xiangdong Fang; Chandra Mohan; Quan-Zhen Li
Journal:  Stem Cell Res Ther       Date:  2014-01-30       Impact factor: 6.832

7.  Neurogenic tachykinin mechanisms in experimental nephritis of rats.

Authors:  Kristina Rodionova; Karl F Hilgers; Eva-Maria Paulus; Gisa Tiegs; Christian Ott; Roland Schmieder; Mario Schiffer; Kerstin Amann; Roland Veelken; Tilmann Ditting
Journal:  Pflugers Arch       Date:  2020-10-17       Impact factor: 3.657

8.  Kallikrein transduced mesenchymal stem cells protect against anti-GBM disease and lupus nephritis by ameliorating inflammation and oxidative stress.

Authors:  Yajuan Li; Indu Raman; Yong Du; Mei Yan; Soyoun Min; Jichen Yang; Xiangdong Fang; Wei Li; Jianxin Lu; Xin J Zhou; Chandra Mohan; Quan-Zhen Li
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.